Targeted genomic profiling of blood from patients with NSCLC after classification with a poor prognosis.

e23051Background: Proteomic signatures have clinical utility, with one example, VeriStrat (VS), measuring acute phase reactant proteins in blood. Patients with EGFRwt tumors and a POOR (VS-P) progn...